Beyond glycemic effects, GLP-1 receptor agonists act on receptors in the central nervous system, particularly in areas regulating appetite and food intake
LW RX Wins Ro Dropped Compounded Semaglutide: After the FDA resolved the semaglutide shortage in February 2025, Ro pivoted to brand-name only medications (Wegovy/Zepbound), dramatically increasing patient costs
He believes that the small risk of having an ocular event cannot be a reason to discourage patients from not taking what can potentially be life-changing medications that have shown remarkable results
The STEP trial program demonstrated approximately 1517% weight loss over 68 weeks (Wilding et al., 2021)
The goal is a plan that feels predictable, with adjustments based on tolerance, appetite patterns, and measurable progress
Ingredients : Water, L-carnitine base, inulin, souring material: citric acid, green tea extract, sweeteners: sucralose, acesulfam-K